Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-cell Lymphoma Targeted Therapy”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Large-scale testing (Phase 3)Looking for participantsNCT05770037
What this trial is testing

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)UnknownNCT04480125
What this trial is testing

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 28
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

Who this might be right for
AMLMyelodysplastic SyndromesALL, Adult
TScan Therapeutics, Inc. 75
Large-scale testing (Phase 3)Enrolling By InvitationNCT05678933
What this trial is testing

AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Who this might be right for
Peripheral T-cell Lymphoma Targeted Therapy
Tianjin Medical University Cancer Institute and Hospital 200
Early research (Phase 1)Not Yet RecruitingNCT06696846
What this trial is testing

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

Who this might be right for
Relapsed/refractory T-cell LymphomaRelapsed/refractory Acute Myeloid Leukemia
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Early research (Phase 1)Study completedNCT01147991
What this trial is testing

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+2 more
Cancer Research UK 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07380984
What this trial is testing

PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Ruijin Hospital 47
Testing effectiveness (Phase 2)Study completedNCT03590574
What this trial is testing

Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

Who this might be right for
T Cell Non-Hodgkin LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma+1 more
Autolus Limited 20
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Very early researchLooking for participantsNCT06224049
What this trial is testing

Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T

Who this might be right for
T-cell Lymphoma
BGI, China 6
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Early research (Phase 1)Looking for participantsNCT07164560
What this trial is testing

Exploratory Study of TRBC1/2-Targeted CAR-T Cell Therapy in Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Refractory/Recurrent Peripheral T-cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 45
Post-approval studies (Phase 4)UnknownNCT03631862
What this trial is testing

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University 100
Testing effectiveness (Phase 2)UnknownNCT04480099
What this trial is testing

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 96
Early research (Phase 1)Ended earlyNCT00093704
What this trial is testing

Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma

Who this might be right for
LymphomaLymphoproliferative Disorder
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Looking for participantsNCT07143929
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

Who this might be right for
CD7 Positive R/R PTCL
Peking University People's Hospital 18
Very early researchNot Yet RecruitingNCT07048353
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Who this might be right for
LymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15